Literature DB >> 30830407

Comparative analysis of creatinine and osmolality as urine normalization strategies in targeted metabolomics for the differential diagnosis of asthma and COPD.

Mona M Khamis1, Teagan Holt1, Hanan Awad2, Anas El-Aneed1, Darryl J Adamko3.   

Abstract

INTRODUCTION: Urine is an ideal matrix for metabolomics investigation due to its non-invasive nature of collection and its rich metabolite content. Despite the advancements in mass spectrometry and 1H-NMR platforms in urine metabolomics, the statistical analysis of the generated data is challenged with the need to adjust for the hydration status of the person. Normalization to creatinine or osmolality values are the most adopted strategies, however, each technique has its challenges that can hinder its wider application. We have been developing targeted urine metabolomic methods to differentiate two important respiratory diseases, namely asthma and chronic obstructive pulmonary disease (COPD).
OBJECTIVE: To assess whether the statistical model of separation of diseases using targeted metabolomic data would be improved by normalization to osmolality instead of creatinine.
METHODS: The concentration of 32 metabolites was previously measured by two liquid chromatography-tandem mass spectrometry methods in 51 human urine samples with either asthma (n = 25) or COPD (n = 26). The data was normalized to creatinine or osmolality. Statistical analysis of the normalized values in each disease was performed using partial least square discriminant analysis (PLS-DA). Models of separation of diseases were compared.
RESULTS: We found that normalization to creatinine or osmolality did not significantly change the PLS-DA models of separation (R2Q2 = 0.919, 0.705 vs R2Q2 = 0.929, 0.671, respectively). The metabolites of importance in the models remained similar for both normalization methods.
CONCLUSION: Our findings suggest that targeted urine metabolomic data can be normalized for hydration using creatinine or osmolality with no significant impact on the diagnostic accuracy of the model.

Entities:  

Keywords:  Creatinine; Metabolomics; Osmolality; PLS-DA; Targeted; Urine normalization

Mesh:

Substances:

Year:  2018        PMID: 30830407     DOI: 10.1007/s11306-018-1418-9

Source DB:  PubMed          Journal:  Metabolomics        ISSN: 1573-3882            Impact factor:   4.290


  32 in total

Review 1.  Measurement of urinary concentration: a critical appraisal of methodologies.

Authors:  V Chadha; U Garg; U S Alon
Journal:  Pediatr Nephrol       Date:  2001-04       Impact factor: 3.714

2.  Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles.

Authors:  Carolyn M Slupsky; Kathryn N Rankin; James Wagner; Hao Fu; David Chang; Aalim M Weljie; Erik J Saude; Bruce Lix; Darryl J Adamko; Sirish Shah; Russ Greiner; Brian D Sykes; Thomas J Marrie
Journal:  Anal Chem       Date:  2007-08-17       Impact factor: 6.986

3.  Metabolomic profiling of asthma and chronic obstructive pulmonary disease: A pilot study differentiating diseases.

Authors:  Darryl J Adamko; Parameswaran Nair; Irvin Mayers; Ross T Tsuyuki; Shana Regush; Brian H Rowe
Journal:  J Allergy Clin Immunol       Date:  2015-07-04       Impact factor: 10.793

Review 4.  The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis.

Authors:  B Fatemeh Nobakht M Gh; Rasoul Aliannejad; Mostafa Rezaei-Tavirani; Salman Taheri; Afsaneh Arefi Oskouie
Journal:  Biomarkers       Date:  2014-11-18       Impact factor: 2.658

5.  Statistics corner: A guide to appropriate use of correlation coefficient in medical research.

Authors:  M M Mukaka
Journal:  Malawi Med J       Date:  2012-09       Impact factor: 0.875

6.  Development of a validated LC- MS/MS method for the quantification of 19 endogenous asthma/COPD potential urinary biomarkers.

Authors:  Mona M Khamis; Darryl J Adamko; Anas El-Aneed
Journal:  Anal Chim Acta       Date:  2017-08-16       Impact factor: 6.558

7.  Evaluation of dilution and normalization strategies to correct for urinary output in HPLC-HRTOFMS metabolomics.

Authors:  Franziska C Vogl; Sebastian Mehrl; Leonhard Heizinger; Inga Schlecht; Helena U Zacharias; Lisa Ellmann; Nadine Nürnberger; Wolfram Gronwald; Michael F Leitzmann; Jerome Rossert; Kai-Uwe Eckardt; Katja Dettmer; Peter J Oefner
Journal:  Anal Bioanal Chem       Date:  2016-11-04       Impact factor: 4.142

8.  Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry.

Authors:  Haleem J Issaq; Ofer Nativ; Timothy Waybright; Brian Luke; Timothy D Veenstra; Elias J Issaq; Alexander Kravstov; Michael Mullerad
Journal:  J Urol       Date:  2008-04-23       Impact factor: 7.450

9.  Urinary metabonomic study on biochemical changes in chronic unpredictable mild stress model of depression.

Authors:  Shuning Zheng; Mingyang Yu; Xiumei Lu; Taoguang Huo; Lin Ge; Jingyu Yang; Chunfu Wu; Famei Li
Journal:  Clin Chim Acta       Date:  2009-11-11       Impact factor: 3.786

10.  Standardization of diagnostic biomarker concentrations in urine: the hematuria caveat.

Authors:  Cherith N Reid; Michael Stevenson; Funso Abogunrin; Mark W Ruddock; Frank Emmert-Streib; John V Lamont; Kate E Williamson
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more
  11 in total

1.  One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m.3243A > G mutation.

Authors:  Karien Esterhuizen; J Zander Lindeque; Shayne Mason; Francois H van der Westhuizen; Richard J Rodenburg; Paul de Laat; Jan A M Smeitink; Mirian C H Janssen; Roan Louw
Journal:  Metabolomics       Date:  2021-01-12       Impact factor: 4.290

2.  Evaluation of statistical techniques to normalize mass spectrometry-based urinary metabolomics data.

Authors:  Tyler Cook; Yinfa Ma; Sanjeewa Gamagedara
Journal:  J Pharm Biomed Anal       Date:  2019-09-03       Impact factor: 3.935

3.  Metabolite quantification: A fluorescence-based method for urine sample normalization prior to 1H-NMR analysis.

Authors:  James Gerard Wolfsberger; Emily C Hunt; Sai Sumedha Bobba; Sharifa Love-Rutledge; Bernhard Vogler
Journal:  Metabolomics       Date:  2022-10-19       Impact factor: 4.747

4.  Comparing Approaches to Normalize, Quantify, and Characterize Urinary Extracellular Vesicles.

Authors:  Charles J Blijdorp; Omar A Z Tutakhel; Thomas A Hartjes; Thierry P P van den Bosch; Martijn H van Heugten; Juan Pablo Rigalli; Rob Willemsen; Usha M Musterd-Bhaggoe; Eric R Barros; Roger Carles-Fontana; Cristian A Carvajal; Onno J Arntz; Fons A J van de Loo; Guido Jenster; Marian C Clahsen-van Groningen; Cathy A Cuevas; David Severs; Robert A Fenton; Martin E van Royen; Joost G J Hoenderop; René J M Bindels; Ewout J Hoorn
Journal:  J Am Soc Nephrol       Date:  2021-03-29       Impact factor: 10.121

5.  Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles.

Authors:  Uta Erdbrügger; Charles J Blijdorp; Irene V Bijnsdorp; Francesc E Borràs; Dylan Burger; Benedetta Bussolati; James Brian Byrd; Aled Clayton; James W Dear; Juan M Falcón-Pérez; Cristina Grange; Andrew F Hill; Harry Holthöfer; Ewout J Hoorn; Guido Jenster; Connie R Jimenez; Kerstin Junker; John Klein; Mark A Knepper; Erik H Koritzinsky; James M Luther; Metka Lenassi; Janne Leivo; Inge Mertens; Luca Musante; Eline Oeyen; Maija Puhka; Martin E van Royen; Catherine Sánchez; Carolina Soekmadji; Visith Thongboonkerd; Volkert van Steijn; Gerald Verhaegh; Jason P Webber; Kenneth Witwer; Peter S T Yuen; Lei Zheng; Alicia Llorente; Elena S Martens-Uzunova
Journal:  J Extracell Vesicles       Date:  2021-05-21

6.  Immune cell profiles of patients with interstitial cystitis/bladder pain syndrome.

Authors:  Robert M Moldwin; Vishaan Nursey; Oksana Yaskiv; Siddhartha Dalvi; Eric J Macdonald; Michael Funaro; Chengliang Zhang; William DeGouveia; Marina Ruzimovsky; Horacio R Rilo; Edmund J Miller; Souhel Najjar; Inna Tabansky; Joel N H Stern
Journal:  J Transl Med       Date:  2022-02-21       Impact factor: 5.531

7.  Comprehensive Targeted Metabolomic Study in the Lung, Plasma, and Urine of PPE/LPS-Induced COPD Mice Model.

Authors:  Hyeon-Young Kim; Hyeon-Seong Lee; In-Hyeon Kim; Youngbae Kim; Moongi Ji; Songjin Oh; Doo-Young Kim; Wonjae Lee; Sung-Hwan Kim; Man-Jeong Paik
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

8.  Pre- and Post-Resection Urine Metabolic Profiles of Bladder Cancer Patients: Results of Preliminary Studies on Time Series Metabolomics Analysis.

Authors:  Julia Jacyna; Marta Kordalewska; Małgorzata Artymowicz; Marcin Markuszewski; Marcin Matuszewski; Michał J Markuszewski
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

9.  Relationship between Urine Creatinine and Urine Osmolality in Spot Samples among Men and Women in the Danish Diet Cancer and Health Cohort.

Authors:  Selinay Ozdemir; Clara G Sears; James M Harrington; Aslak Harbo Poulsen; Jessie Buckley; Chanelle J Howe; Katherine A James; Anne Tjonneland; Gregory A Wellenius; Ole Raaschou-Nielsen; Jaymie Meliker
Journal:  Toxics       Date:  2021-11-01

10.  Normalizing Untargeted Periconceptional Urinary Metabolomics Data: A Comparison of Approaches.

Authors:  Ana K Rosen Vollmar; Nicholas J W Rattray; Yuping Cai; Álvaro J Santos-Neto; Nicole C Deziel; Anne Marie Z Jukic; Caroline H Johnson
Journal:  Metabolites       Date:  2019-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.